Mind Medicine Stock Today


USD 0.67  0.01  1.47%   

Market Performance
0 of 100
Odds Of Distress
Over 61
Mind Medicine is trading at 0.67 as of the 29th of June 2022, a -1.47 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.66. Mind Medicine has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Mind Medicine Mindmed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of May 2022 and ending today, the 29th of June 2022. Click here to learn more.
Fiscal Year End
IPO Date
3rd of March 2020
Mind Medicine Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company has 420.74 M outstanding shares of which 32.23 M shares are now shorted by private and institutional investors with about 13.12 trading days to cover. More on Mind Medicine Mindmed

Moving together with Mind Medicine

0.8BCRXBiocryst Pharma Upward RallyPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Mind Medicine Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Mind Medicine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mind Medicine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Mind Medicine generated a negative expected return over the last 90 days
Mind Medicine has some characteristics of a very speculative penny stock
Mind Medicine has high historical volatility and very poor performance
Mind Medicine has high likelihood to experience some financial distress in the next 2 years
Mind Medicine Mindmed was previously known as MIND MEDICINE INC and was traded on NASDAQ Exchange under the symbol MMEDF.
Net Loss for the year was (93.04 M).
Mind Medicine Mindmed currently holds about 133.54 M in cash with (45.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Mind Medicine has a frail financial position based on the latest SEC disclosures
Roughly 12.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Sale by Karlin Dan of 26238 shares of Mind Medicine
Older SymbolMMEDF
New SymbolMNMD1
Fama & French Classification
Average Analyst Recommendation
Analysts covering Mind Medicine report their recommendations after researching Mind Medicine's financial statements, talking to executives and customers, or listening in on Mind Medicine's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Mind Medicine Mindmed. The Mind Medicine consensus assessment is calculated by taking the average forecast from all of the analysts covering Mind Medicine.
Strong Buy2 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Mind Medicine Mindmed based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Mind Medicine Mindmed financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 2 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares412.1 M410.7 M
Slightly Up
Slightly volatile
Weighted Average Shares Diluted412.1 M410.7 M
Slightly Up
Slightly volatile
Total Assets136 M164 M
Significantly Down
Slightly volatile
Total Liabilities10.3 M12.3 M
Fairly Down
Slightly volatile
Current Assets115.7 M137.2 M
Fairly Down
Slightly volatile
Current Liabilities8.4 M10.4 M
Significantly Down
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Mind Medicine's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Mind Medicine Mindmed (MNMD) is traded on NASDAQ Exchange in USA. It is located in 1055 West Hastings Street and employs 41 people. Mind Medicine Mindmed was previously known as MIND MEDICINE INC and was traded on NASDAQ Exchange under the symbol MMEDF. Mind Medicine is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 277.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mind Medicine's market, we take the total number of its shares issued and multiply it by Mind Medicine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Mind Medicine Mindmed conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 420.74 M outstanding shares of which 32.23 M shares are now shorted by private and institutional investors with about 13.12 trading days to cover. Mind Medicine Mindmed currently holds about 133.54 M in cash with (45.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Check Mind Medicine Probability Of Bankruptcy
Mind Medicine Mindmed holds a total of 420.74 Million outstanding shares. Mind Medicine Mindmed secures 12.49 % if its outstanding shares held by insiders and 12.49 % owned by institutional investors . Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Mind Medicine Ownership Details

Mind Medicine Stock Price Odds Analysis

What are Mind Medicine's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Mind Medicine jumping above the current price in 90 days from now is about 92.34%. The Mind Medicine Mindmed probability density function shows the probability of Mind Medicine stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.5996. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Mind Medicine will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Mind Medicine Mindmed is significantly underperforming DOW.
  Odds Below 0.67HorizonTargetOdds Above 0.67
7.62%90 days
Based on a normal probability distribution, the odds of Mind Medicine to move above the current price in 90 days from now is about 92.34 (This Mind Medicine Mindmed probability density function shows the probability of Mind Medicine Stock to fall within a particular range of prices over 90 days) .

Mind Medicine Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Mind Medicine that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Mind Medicine's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mind Medicine's value.
InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares16.4 M18.2 M
State Street CorpCommon Shares6.1 M6.8 M
Susquehanna International Group LlpCall Options1.6 M1.8 M
Susquehanna International Group LlpPut Options517.1 K574 K
View Mind Medicine Diagnostics

Mind Medicine Historical Income Statement

Mind Medicine Mindmed Income Statement is one of the three primary financial statements used for reporting Mind Medicine's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Mind Medicine Mindmed revenue and expense. Mind Medicine Income Statement primarily focuses on the company's revenues and expenses during a particular period.
View More Fundamentals

Mind Medicine Stock Against Markets

Picking the right benchmark for Mind Medicine stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Mind Medicine stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Mind Medicine is critical whether you are bullish or bearish towards Mind Medicine Mindmed at a given time.

Similar Equity Warning - MNMD

Mind Medicine Mindmed was forked

The entity Mind Medicine Mindmed with a symbol MNMD was recently forked. You can potentially use MINIMED INC with a symbol MNMD1 from now on.

Investing Mind Medicine Mindmed

You need to understand the risk of investing before taking a position in Mind Medicine. The danger of trading Mind Medicine Mindmed is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Mind Medicine is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Mind Medicine. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Mind Medicine Mindmed is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, see Stocks Correlation. Note that the Mind Medicine Mindmed information on this page should be used as a complementary analysis to other Mind Medicine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Mind Medicine Stock analysis

When running Mind Medicine Mindmed price analysis, check to measure Mind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mind Medicine is operating at the current time. Most of Mind Medicine's value examination focuses on studying past and present price action to predict the probability of Mind Medicine's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mind Medicine's price. Additionally, you may evaluate how the addition of Mind Medicine to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Mind Medicine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind Medicine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
294 M
Return On Assets
Return On Equity
The market value of Mind Medicine Mindmed is measured differently than its book value, which is the value of Mind Medicine that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine Mind Medicine value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.